与心脏移植中的功能障碍和移植损失相关的分子状态
Philip F Halloran1, Katelynn Madill-Thomsen1, Martina Mackova1
1Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
概括
心脏移植中的基因表达变化揭示了与功能障碍相关的脱差和炎症. 移植失败风险还涉及微循环问题和缺氧,影响生存率.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 移植科学 移植科学
背景情况:
- 内心肌组织活检对于评估心脏移植健康至关重要.
- 了解基因表达变化是识别功能障碍和移植失败的关键.
研究的目的:
- 确定与心脏移植功能障碍和移植失败相关的基因表达模式.
- 开发用于预测移植后功能障碍和生存的分子分类器.
主要方法:
- 全基因组微阵列分析了19462个基因,在1013个活检中分析了功能障碍和779个生存的基因.
- 左心室喷射分数 (LVEF ≤ 55) 定义的功能障碍.
- 构建了分子分类器来预测LVEF和3年生存率.
主要成果:
- 功能障碍与心脏转录的表达减少 (例如,溶液载体) 和炎症基因增加相关.
- 移植失败的风险涉及微循环基因 (例如,阿尔金酶2,内甲蛋白1),糖解和缺氧反应.
- 增加BNP (NPPB) 表达与功能障碍和移植损失有关.
结论:
- 移植功能障碍涉及脱差,矩阵基因减少,损伤和炎症.
- 短期的移植损失风险受微循环,糖解和缺氧以及功能障碍标志物的影响.
- 预测模型对生存风险进行了分层分层,显示了风险五分位数之间的显著差异.
相关概念视频
Tissue Transplantation
375
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
375
Cell-mediated Immune Responses
68.4K
Overview
68.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333


